Ogundimu, Oluseyi

Ogundimu, Oluseyi was paid $25K by Medicaid between Jan 2018 and Jan 2019, across 4 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 57% of everything it billed.

33Billing provider infoOGUNDIMU, OLUSEYI
SULLIVAN, MO 63080

33aNPI1700016250assigned 07/17/2009

33bProvider typePain Medicine (Anesthesiology) Physician

28Total paid$25K

24GClaims662

24DCodes billed4

24AFirst – last monthJan 2018 – Jan 2019

Compared with peers

Next to other Pain Medicine (Anesthesiology) Physician providers in Missouri

Rank by total paid#15 of 24

Median peer was paid$27K

This provider vs. median0.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	615	$24K
2019	47	$2K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	57%	390	363	$14K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	20%	77	76	$5K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	19%	182	167	$5K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	4.7%	13	12	$1K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.